{"disease":{"id":"vitreous-anomalies","name":"vitreous anomalies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06520410","title":"Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04570007","title":"Vitreous Fragments Length After Pars Plana Vitrectomy","phase":"","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Ospedale Policlinico San Martino","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}